Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population

被引:26
作者
Bossini-Castillo, Lara [1 ]
Simeon, Carmen P. [2 ]
Beretta, Lorenzo [3 ,4 ]
Vonk, Madelon C. [5 ]
Luis Callejas-Rubio, Jose [6 ]
Espinosa, Gerard [7 ]
Carreira, Patricia [8 ]
Camps, Maria T. [9 ]
Rodriguez-Rodriguez, Luis [10 ]
Rodriguez-Carballeira, Monica [11 ]
Garcia-Hernandez, Francisco J. [12 ]
Lopez-Longo, Francisco J. [13 ]
Hernandez-Hernandez, Vanesa [14 ]
Saez-Comet, Luis [15 ]
Egurbide, Maria Victoria [16 ]
Hesselstrand, Roger [17 ]
Nordin, Annika [18 ]
Hoffmann-Vold, Anna-Maria [19 ]
Vanthuyne, Marie [20 ]
Smith, Vanessa [21 ]
De Langhe, Ellen [22 ]
Kreuter, Alexander
Riemekasten, Gabriela [23 ,24 ]
Witte, Torsten [25 ]
Hunzelmann, Nicolas [26 ]
Voskuyl, Alexandre E. [27 ]
Schuerwegh, Annemie J. [28 ]
Lunardi, Claudio [29 ]
Airo, Paolo [30 ]
Scorza, Raffaella [3 ,4 ]
Shiels, Paul [31 ]
van Laar, Jacob M. [32 ]
Fonseca, Carmen [33 ]
Denton, Christopher [32 ]
Herrick, Ariane [34 ]
Worthington, Jane [34 ]
Koeleman, Bobby P. [35 ]
Rueda, Blanca [36 ]
Radstake, Timothy R. D. J. [5 ]
Martin, Javier
机构
[1] CSIC, Inst Parasitol & Biomed Lopez Neyra, Consejo Super Invest Cient, Granada 18100, Spain
[2] Hosp Gen Valle Hebron, Med Interna Serv, Barcelona, Spain
[3] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Referral Ctr System Autoimmune Dis, Milan, Italy
[4] Univ Milan, Milan, Italy
[5] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands
[6] Hosp Clin Univ, Med Interna Serv, Granada, Spain
[7] Hosp Clin Barcelona, Serv Enfermedades Autoinmunes, Barcelona, Spain
[8] Hosp 12 Octubre, Serv Reumatol, E-28041 Madrid, Spain
[9] Hosp Carlos Haya, Med Interna Serv, Malaga, Spain
[10] Hosp Clin San Carlos, Serv Reumatol, Madrid, Spain
[11] Hosp Univ Mutua Terrasa, Med Interna Serv, Barcelona, Spain
[12] Hosp Virgen del Rocio, Med Interna Serv, Seville, Spain
[13] Hosp Gen Univ Gregorio Maranon, Serv Reumatol, Madrid, Spain
[14] Hosp Univ Canarias, Serv Reumatol, Tenerife, Spain
[15] Hosp Univ Miguel Servet, Med Interna Serv, Zaragoza, Spain
[16] Hosp Cruces, Med Interna Serv, Baracaldo, Spain
[17] Lund Univ, Dept Rheumatol, Lund, Sweden
[18] Karolinska Inst, Stockholm, Sweden
[19] Oslo Univ Hosp, Dept Rheumatol, Rikshosp, Oslo, Norway
[20] Catholic Univ Louvain, Clin Univ St Luc, Dept Rheumatol, B-1200 Brussels, Belgium
[21] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium
[22] Katholieke Univ Leuven, Dept Rheumatol, Louvain, Belgium
[23] Ruhr Univ Bochum, Dept Dermatol Venereol & Allergol, Bochum, Germany
[24] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany
[25] Hannover Med Sch, D-3000 Hannover, Germany
[26] Univ Cologne, Dept Dermatol, D-5000 Cologne, Germany
[27] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, Amsterdam, Netherlands
[28] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[29] Univ Verona, Dept Med, I-37100 Verona, Italy
[30] Spedali Civil Brescia, Serv Reumatol Immunol Clin, Brescia, Italy
[31] Univ Glasgow, Div Canc Sci & Mol Pathol, Dept Surg, Glasgow, Lanark, Scotland
[32] Newcastle Univ, James Cook Univ Hosp, Middlesbrough & Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[33] Royal Free & Univ Coll, Sch Med, Ctr Rheumatol, London, England
[34] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[35] Univ Med Ctr Utrecht, Sect Complex Genet, Dept Med Genet, Utrecht, Netherlands
[36] Univ Granada, Escuela Univ Ciencias Salud, Granada, Spain
关键词
Systemic sclerosis; Scleroderma; Macrophage migration inhibitory factor; Polymorphisms; INFLAMMATORY-BOWEL-DISEASE; POLYMORPHISMS; MIF; SUSCEPTIBILITY; SCLERODERMA; EXPRESSION; ARTHRITIS;
D O I
10.1093/rheumatology/ker259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The aim of this study was to confirm the implication of macrophage migration inhibitory factor (MIF) gene in SSc susceptibility or clinical phenotypes in a large European population. Methods. A total of 3800 SSc patients and 4282 healthy controls of white Caucasian ancestry from eight different European countries were included in the study. The MIF -173 single nucleotide polymorphism (SNP) was selected as genetic marker and genotyped using Taqman 5' allelic discrimination assay. Results. The MIF -173 SNP showed association with SSc [P = 0.04, odds ratio (OR) = 1.10, 95% CI 1.00, 1.19]. Analysis of the MIF -173 polymorphism according to SSc clinical phenotype revealed that the frequency of the -173*C allele was significantly higher in the dcSSc group compared with controls (P = 5.30E-03, OR = 1.21, 95% CI 1.07, 1.38). Conversely, the frequency of the MIF -173*C allele was significantly underrepresented in the lcSSc group compared with dcSSc patients, supporting previous findings [(P = 0.04, OR = 0.86, 95% CI 0.75, 0.99); meta-analysis including previous results (P = 0.005, OR = 0.83, 95% CI 0.73, 0.94)]. Conclusion. Our results confirm the role of MIF -173 promoter polymorphism in SSc, and provide evidence of a strong association with the dcSSc subgroup of patients. Hence, the MIF -173 variant is confirmed as a promising clinical phenotype genetic marker.
引用
收藏
页码:1976 / 1981
页数:6
相关论文
共 50 条
[31]   Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis [J].
Dawidowicz, K. ;
Dieude, P. ;
Avouac, J. ;
Wipff, J. ;
Hachulla, E. ;
Diot, E. ;
Tiev, K. ;
Cracowski, J. L. ;
Mouthon, L. ;
Amoura, Z. ;
Frances, C. ;
Carpentier, P. ;
Meyer, O. ;
Kahan, A. ;
Boileau, C. ;
Allanore, Y. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (05) :839-842
[32]   Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan [J].
Shiroeda, Hisakazu ;
Tahara, Tomomitsu ;
Nakamura, Masakatsu ;
Shibata, Tomoyuki ;
Nomura, Tomoe ;
Yamada, Hideto ;
Hayashi, Ranji ;
Saito, Takashi ;
Yamada, Masayoshi ;
Fukuyama, Tomoki ;
Otsuka, Toshimi ;
Yano, Hirokazu ;
Ozaki, Kazuaki ;
Tsuchishima, Mutsumi ;
Tsutsumi, Mikihiro ;
Arisawa, Tomiyasu .
CYTOKINE, 2010, 51 (02) :173-177
[33]   Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea [J].
Khalyfa, Abdelnaby ;
Kheirandish-Gozal, Leila ;
Capdevila, Oscar Sans ;
Bhattacharjee, Rakesh ;
Gozal, David .
PEDIATRIC PULMONOLOGY, 2012, 47 (10) :1001-1011
[34]   Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population [J].
Kawaguchi, Y. ;
Ota, Y. ;
Kawamoto, M. ;
Ito, I. ;
Tsuchiya, N. ;
Sugiura, T. ;
Katsumata, Y. ;
Soejima, M. ;
Sato, S. ;
Hasegawa, M. ;
Fujimoto, M. ;
Takehara, K. ;
Kuwana, M. ;
Yamanaka, H. ;
Hara, M. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (12) :1921-1924
[35]   A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis [J].
Romano, E. ;
Rosa, I. ;
Fioretto, B. S. ;
Kosalka-Wegiel, J. ;
Sticchi, E. ;
Bellando-Randone, S. ;
Manetti, M. ;
Matucci-Cerinic, M. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (10) :1921-1925
[36]   Macrophage migration inhibitory factor [J].
Lolis, E ;
Bucala, R .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (02) :153-164
[37]   Macrophage migration inhibitory factor [J].
Baugh, JA ;
Bucala, R .
CRITICAL CARE MEDICINE, 2002, 30 (01) :S27-S35
[38]   Association of the −173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis [J].
Hiroaki Nohara ;
Naoko Okayama ;
Nagamu Inoue ;
Yuji Koike ;
Kozue Fujimura ;
Yutaka Suehiro ;
Yuichiro Hamanaka ;
Singo Higaki ;
Hideo Yanai ;
Tomoharu Yoshida ;
Toshifumi Hibi ;
Kiwamu Okita ;
Yuji Hinoda .
Journal of Gastroenterology, 2004, 39 :242-246
[39]   Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population [J].
Gomez, L. M. ;
Sanchez, E. ;
Ruiz-Narvaez, E. A. ;
Lopez-Nevot, M. A. ;
Anaya, J.-M. ;
Martin, J. .
TISSUE ANTIGENS, 2007, 70 (01) :28-33
[40]   Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus [J].
Martin, R. J. L. ;
Savage, D. A. ;
Carson, D. J. ;
McKnight, A. J. ;
Maxwell, A. P. ;
Patterson, C. C. .
DIABETIC MEDICINE, 2010, 27 (02) :143-149